Pharmacist Suspended for Unlawful Supply of Controlled Drugs

In a recent determination by the General Pharmaceutical Council (GPhC), a pharmacist was found guilty of serious misconduct related to the unlawful supply of controlled drugs. The case, which was heard remotely via videolink on March 20-21, 2023, involved allegations that the pharmacist supplied Class C controlled drugs, including Diazepam, Zopiclone, Zolpidem, and Nitrazepam, without the necessary Home Office Controlled Drugs Licence (HOCDL) over a period from 2014 to 2016. The pharmacist admitted to the facts of the conviction, which resulted in a 24-month suspended prison sentence.

The GPhC’s Fitness to Practise Committee found the pharmacist’s fitness to practise impaired, primarily on the grounds of public interest. The committee noted that while there was no evidence of actual or potential harm to patients, the pharmacist’s actions brought the profession into disrepute and breached fundamental principles of honesty and integrity. Despite the pharmacist’s reflective account and testimonials indicating remorse and insight, the committee determined that the pharmacist’s integrity could not currently be relied upon.

The determination emphasized the seriousness of the criminal conviction, which involved the unlawful supply of approximately two million tablets of controlled drugs. The committee imposed a 12-month suspension, highlighting the need to uphold the standards and reputation of the pharmacy profession. The decision also included a review before the end of the suspension period to assess the pharmacist’s compliance and further reflection on the fundamental principles of the profession.

For pharmacy professionals, this case underscores the critical importance of adhering to legal and professional requirements, particularly concerning the handling and supply of controlled substances. It serves as a reminder of the potential consequences of failing to maintain the integrity and trustworthiness expected in the profession.